Protocol Citation: Nathan Wright 2025. Large scale EV-A71 2A protease mature and precursor expression setup and operation of Single Use Bubble Column Reactors: Litre-Scale Expression of Recombinant Proteins for Structural Biology and Drug Design (SBDD). protocols.io https://dx.doi.org/10.17504/protocols.io.14egnypbqv5d/v1 License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Protocol status: WorkingWe use this protocol and it's working
Created: June 20, 2025
Last Modified: July 04, 2025
Protocol Integer ID: 220627
Keywords: Single-Use, Bubble Column Reactor, protein production, SBDD, 2A protease, Picornaviridae, E. coli, enterovirus 2a protease variant, inactive coxsackievirus a71 2a protease with c110a mutation, type human coxsackievirus a16 2a protease, a71 2a protease, inactive coxsackievirus a71, type human coxsackievirus a16, scale expression of recombinant protein, recombinant protein production, protein production methodology for structural biology, recombinant protein, protein production methodology, 2a protease, antiviral drug development, sufficient protein quantities for crystallographic study, protein, use bubble column reactor, bubble column reactor, providing sufficient protein quantity, magnetic bead purification, producing wet cell weight, purification, precursor expression setup
Funders Acknowledgements:National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
Grant ID: U19AI171399